GlaxoSmithKline PLC ADR
I · AI-analyse
In het kort
GSK develops and sells vaccines for diseases like RSV, shingles, flu, and HPV, plus specialty treatments for cancer, HIV, and respiratory conditions, and everyday medicines for asthma and infections [COMPANY OVERVIEW]. The company operates globally with manufacturing and research facilities, selling through hospitals, clinics, and pharmacies in over 100 countries. GSK also collaborates with partners like CureVac on mRNA vaccine technology and AN2 Therapeutics on tuberculosis therapies [COMPANY OVERVIEW].
GSK is a major UK-headquartered pharmaceutical company that makes vaccines (RSV, flu, shingles, meningitis), specialty medicines (oncology, HIV, respiratory), and general medicines (asthma, COPD, antibiotics) [COMPANY OVERVIEW]. With $32,7 billion in revenue and a 17,5% net margin, the company is financially healthy and generates $5,8 billion in free cash flow annually [Yahoo Finance]. Recent news shows Japan expanded approval for GSK's RSV vaccine Arexvy to younger at-risk adults, opening a larger market [Nasdaq].
GSK is financially strong with solid profitability, low debt, and healthy cash generation.
Sentinellis-score
7,9/10
Financieel gezond
Marktkapitalisatie
$102,4B
Omzet (12 maanden)
GBP 32,7B
Uitleg
Hoe wij deze cijfers lezen
Begrijpelijke gidsen · geen account nodig
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LezenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LezenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LezenII · Recent nieuws
Wat de koers bewoog
1 bericht · gesorteerd op relevantie
- Macro2026-05-18
GSK: Japan's MHLW Expands Eligible Population For Arexvy
Nasdaq
Premium · gratis met elk account
Dodge & Cox, the second-largest institutional holder at 2,92% of the company, cut its stake by 14,4% in the most recent quarter, a meaningful reduction that could signal concerns about near-term performance or valuation [EODHD].
Risico's
4
Kansen
4
Waarschuwingssignalen
1
Leiding
10
Nog 8 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van GlaxoSmithKline PLC ADR
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 4 risico's, 4 kansen en 1 waarschuwingssignaal — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
III · Vergelijkbare bedrijven
Misschien ook interessant
Zelfde sector · Gezondheidszorg — of vergelijkbare financiële gezondheid
Op je volglijst zetten?